Abiopharma

Kamke Trent G 🟡 adjusted position in 0 shares (2 derivative) of LEMAITRE VASCULAR INC (LMAT) at $48.60 Transaction Date: Jan 08, 2026 | Filing ID: 010637

(10% Negative) Waters Corporation (WAT) Reports Q1 2026 Financial Results

(80% Positive) Amphastar (AMPH) Provides Update on potential for a differentiated safety profile

Lyssikatos Joseph P 🔴 sold 132.5K shares of Enliven Therapeutics, Inc. (ELVN) at $29.13 ($3.5M) Transaction Date: Jan 08, 2026 | Filing ID: 000001

CARVER JENNIFER 🟢 acquired 42.0K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010625

Heyman Richard A. 🔴 sold 13.9K shares of Enliven Therapeutics, Inc. (ELVN) at $25.04 Transaction Date: Jan 08, 2026 | Filing ID: 000004

New Form S-3 - Cingulate Inc. Filed: 2026-01-12 AccNo: 0001493152-26-001891 Size: 1 MB

New Form DEFA14A - HOLOGIC INC Filed: 2026-01-12 AccNo: 0001193125-26-010616 Size: 35 KB

EVNIN LUKE 🔴 sold 91.4K shares of Werewolf Therapeutics, Inc. (HOWL) at $0.63 Transaction Date: Jan 08, 2026 | Filing ID: 000004

ROPER JESS 🟢 acquired 42.0K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010613

Director Dingemans Simon 🟢 acquired 6.2K shares of Avantor, Inc. (AVTR) Transaction Date: Jan 02, 2026 | Filing ID: 001871

VanDuyn Amy Beth 🔴 sold 2.6K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000018

New Form 3 - Avantor, Inc. Filed: 2026-01-12 AccNo: 0001628280-26-001870 Size: 547 KB

Roberts Evan 🔴 sold 6.3K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000017

(10% Negative) Travere Therapeutics, Inc (TVTX) Announces Delay in positioned Trials for successful commercial launch of FILSPARI in FSGS Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment